SAIPARENT stock price is ₹588.1 as of 12 Jul, 2026. The stock intraday movement has stayed between ₹579.50 and ₹608.30, while Sai Parenteral's share price 52 week high low is ₹400.00 & ₹706.00.
In terms of trading activity, SAIPARENT share price has recorded a volume of 3,04,478 shares. The Sai Parenteral's has a market cap of ₹44179231. The stock’s Average Traded Price (ATP) stands at ₹589.62, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 100 @ ₹588.10.
The Sai Parenteral's upper circuit limit is ₹705.70 & The Sai Parenteral's lower circuit limit is ₹470.50, with a Value of ₹17.95 CR. The Delivery Percentage for the day is 56.77%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Sai Parenterals Ltd - 544742 - Announcement under Regulation 30 (LODR)-Change in Management
Sai Parenteral's Board approved the appointment of M/s. Aakanksha Dubey & Co. as Secretarial Auditors, M/s. NSVR & Associates LLP as Internal Auditors, and M/s. Sai Krishna & Associates as Cost Auditors for FY26-27. MD Anil Kumar Karusala was also authorized to identify and explore organic and inorganic growth opportunities.
Jul 06 2026 15:19:57
Sai Parenterals Ltd - 544742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Sai Parenterals' Australian subsidiary, Noumed Pharmaceuticals, renewed its exclusive OTC supply agreement with Australia's leading pharmacy networks. The landmark 7.5-year deal is valued at AUD 202 million (INR 1300 crores), ensuring predictable, recurring revenues and continuous growth with 12 new products annually.
Jul 01 2026 18:15:30
Sai Parenterals Ltd - 544742 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Sai Parenteral's will participate in an analyst and institutional investor group meeting on July 03, 2026. The meeting will be held in-person in Mumbai and hosted by Nirmal Bang Securities. No unpublished price sensitive information will be shared.
Jul 01 2026 16:45:49
Sai Parenterals Ltd - 544742 - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
Sai Parenteral's subsidiary, Noumed Pharmaceuticals, secured an exclusive OTC medicine supply agreement valued at AUD 202 million (INR 1300 crores) with a leading Australian pharmacy network. This 7.5-year agreement significantly boosts the company's international business.
The Buying Price of Sai Parenteral's share is 588.1 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Sai Parenteral's stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Sai Parenteral's, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Sai Parenteral's shares is 181.95. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Sai Parenteral's shares is 3.36. Useful to assess the stock's value relative to its book value.
To assess Sai Parenteral's’s valuation compare Sector P/E, P/B which are 61.72 & 3.24 with sector averages, along with growth rates and financial metrics.
The Market Cap of Sai Parenteral's is 2598.18 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Sai Parenteral's share price is 706.00 & 400.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Sai Parenteral's belongs to the Healthcare sector.